About the audio system
Dr. Kizzmekia Corbett, Lead Scientist, COVID-19 mRNA Vaccine Development; Assistant Professor, Harvard T.H. Chan School of Public Health
Dr. Kizzmekia Corbett was the scientific lead of the Vaccine Research Center’s coronavirus group on the U.S. National Institutes of Health the place she studied coronavirus biology and vaccine improvement. Those 6 years of analysis led to the groundbreaking discovery {that a} stabilized model of a spike protein, which is discovered on the floor of all coronaviruses, can be a key goal for vaccines, therapies, and diagnostics. At the onset of the COVID-19 pandemic, she and her colleagues have been central to the event of the Moderna mRNA vaccine and the Eli Lilly therapeutic monoclonal antibody, each of which have been first to enter medical trials on this planet. As a end result, her work is having a considerable affect on ending the worst respiratory-disease pandemic in additional than 100 years. Dr. Corbett is now an assistant professor within the Department of Immunology and Infectious Diseases on the Harvard T.H. Chan School of Public Health, in addition to the Shutzer Assistant Professor at Harvard’s Radcliffe Institute of Advanced Study and an Associate Member of the Phillip T. and Susan M. Ragon Institute. Her work now extends past the fast improvement of COVID-19 vaccines to the outlook of this pandemic and future viral pandemics.
Perhaps simply as essential as her scientific accomplishments, Dr. Corbett has burst onto the general public stage because the face of a various and rising technology of gifted scientists who will remodel the world. She is a stellar science communicator, explaining the vaccine and the virus in extremely accessible methods to media retailers, two U.S. presidents, and audiences across the globe.
Laurent Duvernay-Tardif, Graduate in Medicine; Super Bowl Champion
Called “the most interesting man in the NFL”, Laurent Duvernay-Tardif is an eight-year NFL veteran, Super Bowl champion, and the one energetic NFL participant with a medical diploma. Just months after his Super Bowl win with the Kansas City Chiefs — and within the midst of the COVID-19 pandemic — Duvernay-Tardif stepped away from soccer to affix the medical entrance strains. From the unbelievable highs of successful the SuperBowl to the burnout of working as an orderly, Duvernay-Tardif shares his outstanding private story, chatting with resiliency, management, and extra.
As plans for the 2020 NFL season ramped up, Duvernay-Tardif stepped away from the sport he beloved, changing into the primary participant of the 2020 NFL season to publicly opt-out. For the primary time in his outstanding profession, Duvernay-Tardif couldn’t reconcile his twin passions of soccer and drugs, and together with his group’s Super Bowl win solely months behind him, he discovered himself on the entrance strains of the pandemic, working in a long-term care facility in Quebec. While engaged on the entrance strains, Duvernay-Tardif enrolled in Harvard’s T.H. Chan School of Public Health.
Juergen Eckhardt, SVP and Head, Leaps by Bayer
Juergen Eckhardt is SVP and Head of Leaps by Bayer, the affect funding unit of Bayer. The mission of Leaps is to spend money on breakthrough applied sciences and disruptive enterprise fashions within the areas of healthcare and agriculture. Juergen has been a enterprise investor since 2002 and at the moment serves on the board of Joyn Bio, Dewpoint, Century, Khloris, Oerth Bio, Immunitas, eGenesis, and others. Previously, Juergen was a administration advisor and Associate Partner with McKinsey & Co. and a member of McKinsey’s Healthcare Leadership Team. He started his profession as a radiologist on the University Hospital of Basel, Switzerland. Juergen obtained his M.D. from the University of Basel and his MBA from INSEAD in Fontainebleau, France.
Elizabeth Bramson-Boudreau, CEO and Publisher, MIT Technology Review
Elizabeth Bramson-Boudreau is the CEO and writer of MIT Technology Review, the Massachusetts Institute of Technology’s impartial media firm.
Since Elizabeth took the helm of MIT Technology Review in mid-2017, the enterprise has undergone a large transformation from its earlier place as a revered however area of interest print journal to a broadly learn, multi-platform media model with a world viewers and a sustainable enterprise. Under her management, MIT Technology Review has been lauded for its editorial authority, its best-in-class occasions, and its novel use of impartial, authentic analysis to help each advertisers and readers.
Elizabeth has a 20-year background in constructing and working groups at world-leading media corporations. She maintains a eager deal with new methods to commercialize media content material to attraction to discerning, demanding shoppers in addition to B2B audiences.
Prior to becoming a member of MIT Technology Review, Elizabeth held a senior govt position at The Economist Group, the place her management stretched throughout enterprise strains and included mergers and acquisitions; editorial and product creation and modernization; gross sales; advertising and marketing; and occasions. Earlier in her profession, she labored as a advisor advising expertise companies on market entry and worldwide enlargement.
Elizabeth holds an govt MBA from the London Business School, an MSc from the London School of Economics, and a bachelor’s diploma from Swarthmore College.